Private equity firm Bridgepoint is poised to refinance Diaverum, Europe’s largest independent renal care service providers. A bank meeting is due to take place next week, according to Reuters.
Bridgepoint has mandated Commerzbank, Credit Agricole CIB, GE Capital, JPMorgan and RBS as bookrunners to arrange the debt needed to refinance its existing loans. Bridgepoint mandated JPMorgan last year to explore options for the company. The company's existing debt comprises €708 million of senior facilities and €176 million of subordinated debt.
To read the full story on Private Debt Investor, click here.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: